TTY focuses on research & development and innovation of antitumor and against severe infection's areas. We will continue to develop in healthcare product portfolio to support the physicians and patients with completed approach to disease treatment.

• In product development, we continuously build win-win business relationships with partners through innovation derived from our successful “specialty sustained release technology platform”, and continuously enhance our production quality and efficiency through designing customized production protocol.
• In manufacturing, TTY owns internationalized factories with high-standard quality controlling process and excellent production management. Our manufacturing base was established according to international standards, and it is able to produce drugs of high competitive barriers and added values for global marketing.
• In marketing, TTY uses the foundation of solid research and development and production capabilities to build global strategic alliances. It also uses self-owned sales teams and company of joint venture to expand markets. TTY now is an innovative, "global marketing and drug development oriented" innovative biotech enterprise.

By the incessant improvement in product development, manufacturing and marketing, TTY strives to become the world leading pharmaceutical company specialized in developing and marketing specialty formulation products and biologics.